Roles of β-Cell Hypoxia in the Progression of Type 2 Diabetes
Abstract
:1. Introduction
2. Induction of Hypoxia in Pancreatic β-Cells by Hyperglycemia
3. Roles of HIFs in Pancreatic β-Cells
4. Roles of Transcriptional Repressors in Hypoxic β-Cells
5. Hypoxia Regulates Several Stress Pathways in β-Cells
6. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Ong, K.L.; Stafford, L.K.; McLaughlin, S.A.; Boyko, E.J.; Vollset, S.E.; Smith, A.E.; Dalton, B.E.; Duprey, J.; Cruz, J.A.; Hagins, H.; et al. Global, Regional, and National Burden of Diabetes from 1990 to 2021, with Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021. Lancet 2023, 402, 203–234. [Google Scholar] [CrossRef] [PubMed]
- DeFronzo, R.A.; Abdul-Ghani, M.A. Preservation of β-Cell Function: The Key to Diabetes Prevention. J. Clin. Endocrinol. Metab. 2011, 96, 2354–2366. [Google Scholar] [CrossRef] [PubMed]
- McCarthy, M.I. Genomics, Type 2 Diabetes, and Obesity. N. Engl. J. Med. 2010, 363, 2339–2350. [Google Scholar] [CrossRef] [PubMed]
- Ling, C.; Rönn, T. Epigenetics in Human Obesity and Type 2 Diabetes. Cell Metab. 2019, 29, 1028–1044. [Google Scholar] [CrossRef] [PubMed]
- Prentki, M.; Nolan, C.J. Islet β Cell Failure in Type 2 Diabetes. J. Clin. Investig. 2006, 116, 1802–1812. [Google Scholar] [CrossRef] [PubMed]
- Kahn, S.E.; Cooper, M.E.; Del Prato, S. Pathophysiology and Treatment of Type 2 Diabetes: Perspectives on the Past, Present, and Future. Lancet 2014, 383, 1068–1083. [Google Scholar] [CrossRef]
- Hudish, L.I.; Reusch, J.E.B.; Sussel, L. β Cell Dysfunction during Progression of Metabolic Syndrome to Type 2 Diabetes. J. Clin. Investig. 2019, 129, 4001–4008. [Google Scholar] [CrossRef] [PubMed]
- Jonas, J.C.; Bensellam, M.; Duprez, J.; Elouil, H.; Guiot, Y.; Pascal, S.M.A. Glucose Regulation of Islet Stress Responses and β-Cell Failure in Type 2 Diabetes. Diabetes Obes. Metab. 2009, 11, 65–81. [Google Scholar] [CrossRef]
- Weir, G.C.; Marselli, L.; Marchetti, P.; Katsuta, H.; Jung, M.H.; Bonner-Weir, S. Towards Better Understanding of the Contributions of Overwork and Glucotoxicity to the β-Cell Inadequacy of Type 2 Diabetes. Diabetes Obes. Metab. 2009, 11, 82–90. [Google Scholar] [CrossRef]
- Bensellam, M.; Laybutt, D.R.; Jonas, J.C. The Molecular Mechanisms of Pancreatic β-Cell Glucotoxicity: Recent Findings and Future Research Directions. Mol. Cell. Endocrinol. 2012, 364, 1–27. [Google Scholar] [CrossRef]
- Sato, Y.; Endo, H.; Okuyama, H.; Takeda, T.; Iwahashi, H.; Imagawa, A.; Yamagata, K.; Shimomura, I.; Inoue, M. Cellular Hypoxia of Pancreatic β-Cells Due to High Levels of Oxygen Consumption for Insulin Secretion in Vitro. J. Biol. Chem. 2011, 286, 12524–12532. [Google Scholar] [CrossRef] [PubMed]
- Bensellam, M.; Duvillié, B.; Rybachuk, G.; Laybutt, D.R.; Magnan, C.; Guiot, Y.; Pouysségur, J.; Jonas, J.-C. Glucose-Induced O₂ Consumption Activates Hypoxia Inducible Factors 1 and 2 in Rat Insulin-Secreting Pancreatic Beta-Cells. PLoS ONE 2012, 7, e29807. [Google Scholar] [CrossRef] [PubMed]
- Zheng, X.; Zheng, X.; Wang, X.; Ma, Z.; Gupta Sunkari, V.; Botusan, I.; Takeda, T.; Björklund, A.; Inoue, M.; Catrina, S.B.; et al. Acute Hypoxia Induces Apoptosis of Pancreatic β-Cell by Activation of the Unfolded Protein Response and Upregulation of CHOP. Cell Death Dis. 2012, 3, e322. [Google Scholar] [CrossRef] [PubMed]
- Gunton, J.E. Hypoxia-Inducible Factors and Diabetes. J. Clin. Investig. 2020, 130, 5063–5073. [Google Scholar] [CrossRef] [PubMed]
- Catrina, S.B.; Zheng, X. Hypoxia and Hypoxia-Inducible Factors in Diabetes and Its Complications. Diabetologia 2021, 64, 709–716. [Google Scholar] [CrossRef] [PubMed]
- Rorsman, P.; Renström, E. Insulin Granule Dynamics in Pancreatic Beta Cells. Diabetologia 2003, 46, 1029–1045. [Google Scholar] [CrossRef] [PubMed]
- Wang, W.; Upshaw, L.; Strong, D.M.; Robertson, R.P.; Reems, J.A. Increased Oxygen Consumption Rates in Response to High Glucose Detected by a Novel Oxygen Biosensor System in Non-Human Primate and Human Islets. J. Endocrinol. 2005, 185, 445–455. [Google Scholar] [CrossRef] [PubMed]
- Carlsson, P.O.; Andersson, A.; Jansson, L. Pancreatic Islet Blood Flow in Normal and Obese-Hyperglycemic (Ob/Ob) Mice. Am. J. Physiol. Endocrinol. Metab. 1996, 271, E990–E995. [Google Scholar] [CrossRef]
- Spencer, J.A.; Ferraro, F.; Roussakis, E.; Klein, A.; Wu, J.; Runnels, J.M.; Zaher, W.; Mortensen, L.J.; Alt, C.; Turcotte, R.; et al. Direct Measurement of Local Oxygen Concentration in the Bone Marrow of Live Animals. Nature 2014, 508, 269–273. [Google Scholar] [CrossRef]
- Carlsson, P.O.; Liss, P.; Andersson, A.; Jansson, L. Measurements of Oxygen Tension in Native and Transplanted Rat Pancreatic Islets. Diabetes 1998, 47, 1027–1032. [Google Scholar] [CrossRef]
- Solaini, G.; Baracca, A.; Lenaz, G.; Sgarbi, G. Hypoxia and Mitochondrial Oxidative Metabolism. Biochim. Biophys. Acta Bioenerg. 2010, 1797, 1171–1177. [Google Scholar] [CrossRef] [PubMed]
- Sato, Y.; Inoue, M.; Yoshizawa, T.; Yamagata, K. Moderate Hypoxia Induces β-Cell Dysfunction with HIF-1-Independent Gene Expression Changes. PLoS ONE 2014, 9, e114868. [Google Scholar] [CrossRef] [PubMed]
- Tsuyama, T.; Sato, Y.; Yoshizawa, T.; Matsuoka, T.; Yamagata, K. Hypoxia Causes Pancreatic Β-cell Dysfunction and Impairs Insulin Secretion by Activating the Transcriptional Repressor BHLHE40. EMBO Rep. 2023, 24, e56227. [Google Scholar] [CrossRef] [PubMed]
- Gerber, P.A.; Rutter, G.A. The Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus. Antioxid. Redox Signal. 2017, 26, 501–518. [Google Scholar] [CrossRef] [PubMed]
- Bensellam, M.; Jonas, J.C.; Laybutt, D.R. Mechanisms of β-Cell Dedifferentiation in Diabetes: Recent Findings and Future Research Directions. J. Endocrinol. 2018, 236, R109–R143. [Google Scholar] [CrossRef] [PubMed]
- Semenza, G.L. Vasculogenesis, Angiogenesis, and Arteriogenesis: Mechanisms of Blood Vessel Formation and Remodeling. J. Cell Biochem. 2007, 102, 840–847. [Google Scholar] [CrossRef] [PubMed]
- Lee, P.; Chandel, N.S.; Simon, M.C. Cellular Adaptation to Hypoxia through Hypoxia Inducible Factors and Beyond. Nat. Rev. Mol. Cell. Biol. 2020, 21, 268–283. [Google Scholar] [CrossRef] [PubMed]
- Keith, B.; Johnson, R.S.; Simon, M.C. HIF1 α and HIF2 α: Sibling Rivalry in Hypoxic Tumour Growth and Progression. Nat. Rev. Cancer 2011, 12, 9–22. [Google Scholar] [CrossRef] [PubMed]
- Hoang, M.; Jentz, E.; Janssen, S.M.; Nasteska, D.; Cuozzo, F.; Hodson, D.J.; Tupling, A.R.; Fong, G.H.; Joseph, J.W. Isoform-Specific Roles of Prolyl Hydroxylases in the Regulation of Pancreatic β-Cell Function. Endocrinology 2022, 163, bqab226. [Google Scholar] [CrossRef]
- Cheng, K.; Ho, K.; Stokes, R.; Scott, C.; Lau, S.M.; Hawthorne, W.J.; Connell, P.J.O.; Loudovaris, T.; Kay, T.W.; Kulkarni, R.N.; et al. Hypoxia-Inducible Factor-1α Regulates β Cell Function in Mouse and Human Islets. J. Clin. Investig. 2010, 120, 2171–2183. [Google Scholar] [CrossRef]
- Guillam, M.T.; Hümmler, E.; Schaerer, E.; Wu, J.Y.; Birnbaum, M.J.; Beermann, F.; Schmidt, A.; Dériaz, N.; Thorens, B. Early Diabetes and Abnormal Postnatal Pancreatic Islet Development in Mice Lacking Glut-2. Nat. Genet. 1997, 17, 327–330. [Google Scholar] [CrossRef] [PubMed]
- Matschinsky, F.M. Glucokinase, Glucose Homeostasis, and Diabetes Mellitus. Curr. Diab. Rep. 2005, 5, 171–176. [Google Scholar] [CrossRef]
- Lalwani, A.; Warren, J.; Liuwantara, D.; Hawthorne, W.J.; O’Connell, P.J.; Gonzalez, F.J.; Stokes, R.A.; Chen, J.; Laybutt, D.R.; Craig, M.E.; et al. β Cell Hypoxia-Inducible Factor-1α Is Required for the Prevention of Type 1 Diabetes. Cell Rep. 2019, 27, 2370–2384.e6. [Google Scholar] [CrossRef] [PubMed]
- Nomoto, H.; Pei, L.; Montemurro, C.; Rosenberger, M.; Furterer, A.; Coppola, G.; Nadel, B.; Pellegrini, M.; Gurlo, T.; Butler, P.C.; et al. Activation of the HIF1α/PFKFB3 Stress Response Pathway in Beta Cells in Type 1 Diabetes. Diabetologia 2020, 63, 149–161. [Google Scholar] [CrossRef] [PubMed]
- Gunton, J.E.; Kulkarni, R.N.; Yim, S.H.; Okada, T.; Hawthorne, W.J.; Tseng, Y.H.; Roberson, R.S.; Ricordi, C.; O’Connell, P.J.; Gonzalez, F.J.; et al. Loss of ARNT/HIF1β Mediates Altered Gene Expression and Pancreatic-Islet Dysfunction in Human Type 2 Diabetes. Cell 2005, 122, 337–349. [Google Scholar] [CrossRef] [PubMed]
- Pillai, R.; Paglialunga, S.; Hoang, M.; Cousteils, K.; Prentice, K.J.; Bombardier, E.; Huang, M.; Gonzalez, F.J.; Tupling, A.R.; Wheeler, M.B.; et al. Deletion of ARNT/HIF1β in Pancreatic Beta Cells Does Not Impair Glucose Homeostasis in Mice, but Is Associated with Defective Glucose Sensing Ex Vivo. Diabetologia 2015, 58, 2832–2842. [Google Scholar] [CrossRef]
- Zheng, X.; Narayanan, S.; Xu, C.; Angelstig, S.E.; Grünler, J.; Zhao, A.; Di Toro, A.; Bernardi, L.; Mazzone, M.; Carmeliet, P.; et al. Repression of Hypoxia-Inducible Factor-1 Contributes to Increased Mitochondrial Reactive Oxygen Species Production in Diabetes. eLife 2022, 11, e70714. [Google Scholar] [CrossRef] [PubMed]
- Ilegems, E.; Bryzgalova, G.; Correia, J.; Yesildag, B.; Berra, E.; Ruas, J.L.; Pereira, T.S.; Berggren, P.O. HIF-1α Inhibitor PX-478 Preserves Pancreatic β Cell Function in Diabetes. Sci. Transl. Med. 2022, 14, eaba9112. [Google Scholar] [CrossRef] [PubMed]
- Zehetner, J.; Danzer, C.; Collins, S.; Eckhardt, K.; Gerber, P.A.; Ballschmieter, P.; Galvanovskis, J.; Shimomura, K.; Ashcroft, F.M.; Thorens, B.; et al. PVHL Is a Regulator of Glucose Metabolism and Insulin Secretion in Pancreatic β Cells. Genes Dev. 2008, 22, 3135–3146. [Google Scholar] [CrossRef]
- Cantley, J.; Selman, C.; Shukla, D.; Abramov, A.Y.; Forstreuter, F.; Esteban, M.A.; Claret, M.; Lingard, S.J.; Clements, M.; Harten, S.K.; et al. Deletion of the von Hippel-Lindau Gene in Pancreatic β Cells Impairs Glucose Homeostasis in Mice. J. Clin. Investig. 2009, 119, 125–135. [Google Scholar] [CrossRef]
- Puri, S.; Cano, D.A.; Hebrok, M. A Role for von Hippel-Lindau Protein in Pancreatic β-Cell Function. Diabetes 2009, 58, 433–441. [Google Scholar] [CrossRef] [PubMed]
- Semenza, G.L. HIF-1 Mediates Metabolic Responses to Intratumoral Hypoxia and Oncogenic Mutations. J. Clin. Investig. 2013, 123, 3664–3671. [Google Scholar] [CrossRef] [PubMed]
- Maechler, P.; Wollheim, C.B. Mitochondrial Function in Normal and Diabetic β-Cells. Nature 2001, 414, 807–812. [Google Scholar] [CrossRef] [PubMed]
- Moon, J.S.; Riopel, M.; Seo, J.B.; Herrero-Aguayo, V.; Isaac, R.; Lee, Y.S. HIF-2α Preserves Mitochondrial Activity and Glucose Sensing in Compensating β-Cells in Obesity. Diabetes 2022, 71, 1508–1524. [Google Scholar] [CrossRef] [PubMed]
- Lu, H.; Koshkin, V.; Allister, E.M.; Gyulkhandanyan, A.V.; Wheeler, M.B. Molecular and Metabolic Evidence for Mitochondrial Defects Associated with β-Cell Dysfunction in a Mouse Model of Type 2 Diabetes. Diabetes 2010, 59, 448–459. [Google Scholar] [CrossRef] [PubMed]
- Fex, M.; Nicholas, L.M.; Vishnu, N.; Medina, A.; Sharoyko, V.V.; Nicholls, D.G.; Spégel, P.; Mulder, H. The Pathogenetic Role of β-Cell Mitochondria in Type 2 Diabetes. J. Endocrinol. 2018, 236, R145–R159. [Google Scholar] [CrossRef] [PubMed]
- Scortegagna, M.; Ding, K.; Oktay, Y.; Gaur, A.; Thurmond, F.; Yan, L.J.; Marck, B.T.; Matsumoto, A.M.; Shelton, J.M.; Richardson, J.A.; et al. Multiple Organ Pathology, Metabolic Abnormalities and Impaired Homeostasis of Reactive Oxygen Species in Epas1-/- Mice. Nat. Genet. 2003, 35, 331–340. [Google Scholar] [CrossRef] [PubMed]
- Cavadas, M.A.S.; Cheong, A.; Taylor, C.T. The Regulation of Transcriptional Repression in Hypoxia. Exp. Cell Res. 2017, 356, 173–181. [Google Scholar] [CrossRef]
- Gerber, P.A.; Bellomo, E.A.; Hodson, D.J.; Meur, G.; Solomou, A.; Mitchell, R.K.; Hollinshead, M.; Chimienti, F.; Bosco, D.; Hughes, S.J.; et al. Hypoxia Lowers SLC30A8/ZnT8 Expression and Free Cytosolic Zn2+ in Pancreatic Beta Cells. Diabetologia 2014, 57, 1635–1644. [Google Scholar] [CrossRef]
- St-Pierre, B.; Flock, G.; Zacksenhaus, E.; Egan, S.E. Stra13 Homodimers Repress Transcription through Class B E-Box Elements. J. Biol. Chem. 2002, 277, 46544–46551. [Google Scholar] [CrossRef]
- Sato, F.; Bhawal, U.K.; Yoshimura, T.; Muragaki, Y. DEC1 and DEC2 Crosstalk between Circadian Rhythm and Tumor Progression. J. Cancer 2016, 7, 153–159. [Google Scholar] [CrossRef]
- Zhang, C.; Moriguchi, T.; Kajihara, M.; Esaki, R.; Harada, A.; Shimohata, H.; Oishi, H.; Hamada, M.; Morito, N.; Hasegawa, K.; et al. MafA Is a Key Regulator of Glucose-Stimulated Insulin Secretion. Mol. Cell. Biol. 2005, 25, 4969–4976. [Google Scholar] [CrossRef] [PubMed]
- Cataldo, L.R.; Singh, T.; Achanta, K.; Bsharat, S.; Prasad, R.B.; Luan, C.; Renström, E.; Eliasson, L.; Artner, I. MAFA and MAFB Regulate Exocytosis-Related Genes in Human β-Cells. Acta Physiol. 2022, 234, e13761. [Google Scholar] [CrossRef]
- Puigserver, P.; Spiegelman, B.M. Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α (PGC-1α): Transcriptional Coactivator and Metabolic Regulator. Endocr. Rev. 2003, 24, 78–90. [Google Scholar] [CrossRef]
- Li, D.; Yin, X.; Zmuda, E.J.; Wolford, C.C.; Dong, X.; White, M.F.; Hai, T. The Repression of IRS2 Gene by ATF3, a Stress-Inducible Gene, Contributes to Pancreatic β-Cell Apoptosis. Diabetes 2008, 57, 635–644. [Google Scholar] [CrossRef] [PubMed]
- Zmuda, E.J.; Qi, L.; Zhu, M.X.; Mirmira, R.G.; Montminy, M.R.; Hai, T. The Roles of ATF3, an Adaptive-Response Gene, in High-Fat-Diet-Induced Diabetes and Pancreatic β-Cell Dysfunction. Mol. Endocrinol. 2010, 24, 1423–1433. [Google Scholar] [CrossRef]
- Ku, H.C.; Cheng, C.F. Master Regulator Activating Transcription Factor 3 (ATF3) in Metabolic Homeostasis and Cancer. Front. Endocrinol. 2020, 11, 556. [Google Scholar] [CrossRef]
- Mihaylova, M.M.; Shaw, R.J. The AMPK Signalling Pathway Coordinates Cell Growth, Autophagy and Metabolism. Nat. Cell. Biol. 2011, 13, 1016–1023. [Google Scholar] [CrossRef] [PubMed]
- Garcia, D.; Shaw, R.J. AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance. Mol. Cell 2017, 66, 789–800. [Google Scholar] [CrossRef]
- Yamagata, K.; Furuta, H.; Oda, N.; Kaisaki, P.J.; Menzel, S.; Cox, N.J.; Fajans, S.S.; Signorini, S.; Stoffel, M.; Bell, G.I. Mutations in the Hepatocyte Nuclear Factor-4α Gene in Maturity-Onset Diabetes of the Young (MODY1). Nature 1996, 384, 458–460. [Google Scholar] [CrossRef]
- Miura, A.; Yamagata, K.; Kakei, M.; Hatakeyama, H.; Takahashi, N.; Fukui, K.; Nammo, T.; Yoneda, K.; Inoue, Y.; Sladek, F.M.; et al. Hepatocyte Nuclear Factor-4α Is Essential for Glucose-Stimulated Insulin Secretion by Pancreatic β-Cells. J. Biol. Chem. 2006, 281, 5246–5257. [Google Scholar] [CrossRef] [PubMed]
- Sato, Y.; Tsuyama, T.; Sato, C.; Karim, M.F.; Yoshizawa, T.; Inoue, M.; Yamagata, K. Hypoxia Reduces HNF4α/MODY1 Protein Expression in Pancreatic β-Cells by Activating AMP-Activated Protein Kinase. J. Biol. Chem. 2017, 292, 8716–8728. [Google Scholar] [CrossRef] [PubMed]
- Wang, M.; Kaufman, R.J. Protein Misfolding in the Endoplasmic Reticulum as a Conduit to Human Disease. Nature 2016, 529, 326–335. [Google Scholar] [CrossRef] [PubMed]
- Metcalf, M.G.; Higuchi-Sanabria, R.; Garcia, G.; Kimberly Tsui, C.; Dillin, A. Beyond the Cell Factory: Homeostatic Regulation of and by the UPRER. Sci. Adv. 2020, 6, eabb9614. [Google Scholar] [CrossRef] [PubMed]
- Bensellam, M.; Maxwell, E.L.; Chan, J.Y.; Luzuriaga, J.; West, P.K.; Jonas, J.C.; Gunton, J.E.; Laybutt, D.R. Hypoxia Reduces ER-to-Golgi Protein Trafficking and Increases Cell Death by Inhibiting the Adaptive Unfolded Protein Response in Mouse Beta Cells. Diabetologia 2016, 59, 1492–1502. [Google Scholar] [CrossRef] [PubMed]
- Kaneto, H.; Katakami, N.; Matsuhisa, M.; Matsuoka, T.A. Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis. Mediat. Inflamm. 2010, 2010, 453892. [Google Scholar] [CrossRef] [PubMed]
- Kitamura, T. The Role of FOXO1 in β-Cell Failure and Type 2 Diabetes Mellitus. Nat. Rev. Endocrinol. 2013, 9, 615–623. [Google Scholar] [CrossRef] [PubMed]
- Guzy, R.D.; Hoyos, B.; Robin, E.; Chen, H.; Liu, L.; Mansfield, K.D.; Simon, M.C.; Hammerling, U.; Schumacker, P.T. Mitochondrial Complex III Is Required for Hypoxia-Induced ROS Production and Cellular Oxygen Sensing. Cell Metab. 2005, 1, 401–408. [Google Scholar] [CrossRef] [PubMed]
- Semenza, G.L. Hypoxia-inducible Factors: Coupling Glucose Metabolism and Redox Regulation with Induction of the Breast Cancer Stem Cell Phenotype. EMBO J. 2017, 36, 252–259. [Google Scholar] [CrossRef]
- Podkalicka, P.; Stępniewski, J.; Mucha, O.; Kachamakova-Trojanowska, N.; Dulak, J.; Łoboda, A. Hypoxia as a Driving Force of Pluripotent Stem Cell Reprogramming and Differentiation to Endothelial Cells. Biomolecules 2020, 10, 1614. [Google Scholar] [CrossRef]
- Hu, Y.; Lu, H.; Li, H.; Ge, J. Molecular Basis and Clinical Implications of HIFs in Cardiovascular Diseases. Trends Mol. Med. 2022, 28, 916–938. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Yamagata, K.; Tsuyama, T.; Sato, Y. Roles of β-Cell Hypoxia in the Progression of Type 2 Diabetes. Int. J. Mol. Sci. 2024, 25, 4186. https://doi.org/10.3390/ijms25084186
Yamagata K, Tsuyama T, Sato Y. Roles of β-Cell Hypoxia in the Progression of Type 2 Diabetes. International Journal of Molecular Sciences. 2024; 25(8):4186. https://doi.org/10.3390/ijms25084186
Chicago/Turabian StyleYamagata, Kazuya, Tomonori Tsuyama, and Yoshifumi Sato. 2024. "Roles of β-Cell Hypoxia in the Progression of Type 2 Diabetes" International Journal of Molecular Sciences 25, no. 8: 4186. https://doi.org/10.3390/ijms25084186